Sinovac launches clinical trial of Covid-19 vaccine on children in South Africa
JOHANNESBURG: Chinese pharmaceutical company Sinovac Biotech on Friday launched the Phase III clinical trial of its Covid-19 vaccine on a group of children and teenagers between six months and 17 years old in South Africa. The study, carried out in collaboration with South African company Numolux Group, has enrolled approximately 2,000 participants in the country, … Read more